International Clinical Psychopharmacology

Papers
(The H4-Index of International Clinical Psychopharmacology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?37
The role of personality traits in following quarantine orders during the COVID-19 pandemic33
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia19
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?18
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder15
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?14
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial14
Antidepressant psychopharmacology: is inflammation a future target?14
Clinical specificity profile for novel rapid acting antidepressant drugs14
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure14
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge12
Open issues in bipolar and antipsychotic treatments11
Case series on aripiprazole and dopamine supersensitivity psychosis11
0.024752855300903